Clinical trial
Prostate Cancer Genetic Risk Evaluation and Screening Study
NCT05129605
Study timeline
Study start (actual)2020-02-12Date precision: day
Registry last updated2024-10-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostatic Neoplasmunresolved
Prostate Cancerunresolved
BRCA2 Mutationunresolved
BRCA1 Mutationunresolved
ATM Gene Mutationunresolved
MMR Mutationunresolved
Lynch Syndromeunresolved
Genetic Predisposition to Diseaseunresolved
Interventions
Prostate cancer screeningDIAGNOSTIC_TEST
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05129605 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.